Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last ...
The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...
Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback